37 results
8-K
EX-99.1
BTAX
Biostax Corp.
2 Nov 23
Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors
9:00am
or treatment for specific medical conditions. Always seek the advice of your physician or other qualified health care provider with any questions you may
8-K
EX-99.1
BTAX
Biostax Corp.
24 Oct 23
Amendments to Articles of Incorporation or Bylaws
9:00am
seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition
8-K
EX-99.1
BTAX
Biostax Corp.
20 Apr 23
Entry into a Material Definitive Agreement
9:00am
qualified health care provider with any questions you may have regarding a medical condition. This information is not intended to diagnose, treat, cure
8-K
EX-99.1
uxdytrbr 8vjpko5
9 Nov 22
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-99.1
szmgcy
27 Sep 22
Immune Therapeutics Appoints H. Louis Salomonksy to its Board of Directors
2:37pm
D
thbo1 d7arjzj
31 Aug 22
$5M in debt
2:58pm
8-K
EX-99.1
2wfnmecusf
4 Aug 22
Immune Therapeutics Appoints Chief Financial Officer and Chief Operating Officer
1:00pm
8-K
EX-99.1
pc27bollx8kg
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm
S-1
m869qg37m89mw tb719
14 Oct 16
IPO registration
12:00am
DRS/A
4pkombaqtbu9j vkns2y
14 Oct 16
Draft registration statement (amended)
12:00am